NOAH Compendium

Printed from NOAH Compendium (https://www.noahcompendium.co.uk). (c) Copyright NOAH Compendium 2024. All Rights Reserved.
Date: Monday, April 29, 2024 0:29

Description: MSD-AH
Release 5.84
Metricure® 500 mg Intrauterine Suspension
 
Species: Cattle
Therapeutic indication: Pharmaceuticals: Antimicrobials: Uterine products
Active ingredient: Cephapirin
Product:Metricure® 500 mg Intrauterine Suspension
Product index: Metricure®
Cattle - milk: Zero hours
Cattle - meat: 1 day
Incorporating:
Qualitative and quantitative composition
Each syringe contains: Cefapirin 500 mg (as Cefapirin benzathine)
For the full list of excipients, see section “Pharmaceutical particulars”.
Pharmaceutical form
Intrauterine suspension. Cream coloured homogenous suspension.
Clinical particulars
Target Species
Cows
Indications for use
Metricure is indicated for the treatment of subacute and chronic endometritis in cows (at least 14 days after parturition) caused by bacteria sensitive to cefapirin.
Contraindications
Do not administer to animals known to be allergic to cephalosporins or penicillins.
Special warnings for each target species
None
Special precautions for use
Use of the product should be based on susceptibility testing of the bacteria isolated from the animal. If this is not possible, therapy should be based on local (regional, farm level) epidemiological information about susceptibility of the target bacteria.
Operator warnings
Accidental spillage on the skin should be washed off immediately with soap and water.
Penicillin and cephalosporins may cause hypersensitivity (allergy) following injection, inhalation, ingestion or skin contact. Hypersensitivity to penicillin may lead to cross reactions to cephalosporins and vice versa.
Allergic reactions to these substances are occasionally serious.
1. Do not handle this product if you know you are sensitised or if you have been advised not to work with such preparations.
2. Handle this product with great care to avoid exposure, taking all recommended precautions.
3. If you develop symptoms following exposure, such as a skin rash, you should seek medical advice and show the doctor this warning. Swelling of the face, lips or eyes or difficulty with breathing are more serious symptoms and require urgent medical attention.
Wash hands after use.
Adverse Reactions
Allergic reactions have been observed in very rare cases.
The frequency of adverse reactions is defined using the following convention:
∙ very common (more than 1 in 10 animals displaying adverse reaction(s) during the course of one treatment)
∙ common (more than 1 but less than 10 animals in 100 animals)
∙ uncommon (more than 1 but less than 10 animals in 1,000 animals)
∙ rare (more than 1 but less than 10 animals in 10,000 animals)
∙ very rare (less than 1 animal in 10,000 animals, including isolated reports).
Use during pregnancy or lactation
The product is not indicated for use during pregnancy but can be used during lactation.
Interactions
Not to be administered concurrently with other intra-uterine antibiotic preparations.
Amounts to be administered and administration route
The contents of one Metricure syringe should be introduced into the lumen of the uterus using the disposable catheter provided as follows:
1. Shake the syringe before use.
2. Fix the syringe to the catheter.
3. Hold the cervix of the uterus with one gloved hand introduced into the rectum
4. Introduce the catheter through the cervix into the lumen of the uterus, by gentle oscillating movements of the cervix.
5. Inject Metricure.
Depending on the response, a second treatment 7-14 days later may be required in some cases if clinical signs persist.
In animals that have been inseminated, Metricure may be used at one day after insemination. In cases of pyometra, pre-treatment with prostaglandin is recommended in order to induce luteolysis and remove debris from the uterine cavity.
Overdose
Product supplied as a single dose syringe therefore overdose unlikely to occur.
Withdrawal periods
Meat - 1 day
Milk - Zero hours
Pharmacological particulars
ATC Vet Code: QG51AA05
Pharmacotherapeutic group
Pharmacodynamic properties
Cefapirin, a first generation cephalosporin, is a broad spectrum antibiotic with bactericidal action against gram-positive and gram-negative bacteria. Cefapirin is resistant to the action of penicillinase.
Pharmacokinetic particulars
After intra-uterine treatment systemic absorption is low, which is reflected by the low plasma levels of cefapirin observed shortly after treatment. Twelve hours after treatment, cefapirin levels in plasma are below detectable levels.
After intra-uterine administration of Metricure, high cefapirin concentrations are observed in endometrium.
Cefapirin concentrations in endometrium can be observed up to 24 hours
Pharmaceutical particulars
Excipients
Alcohol (C16-C18) 12 mole ethoxylate
Cetomagrocol 1000
Castor oil, hydrogenated
Coconut oil, fractionated
Major incompatibilities
None known
Shelf-life
Shelf life of the veterinary medicinal product as packaged for sale: 3 years
Special precautions for storage
Do not store above 25oC. Syringes are for single use only. Keep syringe in outer carton.
Immediate packaging
High density polyethylene syringe barrel with low density polyethylene plunger and cap containing 19 g of suspension, packed in boxes of 12 syringes. Intra-uterine catheters are provided for administration.
Disposal
Any unused veterinary medicinal product or waste materials derived from such veterinary medicinal products should be disposed of in accordance with local requirements.
Marketing Authorisation Holder (if different from distributor)
Marketing Authorisation Number
UK: Vm 01708/4316
Significant changes
Date of the first authorisation or date of renewal
14 October 2003.
Date of revision of the text
December 2020.
Any other information
For animal treatment only. Keep out of the sight and reach of children.
Legal category
Legal category: POM-V
GTIN
GTIN description:Metricure 1x12 inj:
GTIN:8713184030153